Twynsta (telmisartan/amlodipine) Tablets

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) 

January 2016

ADVERSE REACTIONS

Postmarketing Experience

Amlodipine

… Postmarketing reporting has also revealed a...

Source: Drugs.com - Labeling Changes - January 1, 2016 Category: Drugs & Pharmacology Source Type: alerts